Treatment of Common Respiratory Tract Infections
Treatment of Common Respiratory Tract Infections
April 17, 2023 (Issue: 1674)
Most respiratory tract infections are caused by
viruses. Bacterial respiratory tract infections are
usually treated empirically with antibiotic therapy
that targets the most probable causative pathogens.
Recommended antibiotic regimens for...more
- ST Shulman et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012; 55:1279. doi:10.1093/cid/cis847
- GP DeMuri et al. Macrolide and clindamycin resistance in group A streptococci isolated from children with pharyngitis. Pediatr Infect Dis J 2017; 36:342. doi:10.1097/inf.0000000000001442
- CDC. Antibiotic resistance threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. Available at: https://bit.ly/3LTYOwM. Accessed March 30, 2023.
- AW Chow et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54:e72. doi:10.1093/cid/cir1043
- RM Rosenfeld et al. Clinical practice guideline (update): adult sinusitis executive summary. Otolaryngol Head Neck Surg 2015; 152:598. doi:10.1177/0194599815574247
- AM Harris et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 2016; 164:425. doi:10.7326/m15-1840
- FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. May 12, 2016. Available at: http://bit.ly/3LKT7Bc. Accessed March 30, 2023.
- RJ Zagursky and ME Pichichero. Cross-reactivity in β-lactam allergy. J Allergy Clin Immunol Pract 2018; 6:72. doi:10.1016/j.jaip.2017.08.027
- R Kaur et al. Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV-13) pneumococcal conjugate vaccination during 2015-2019. Eur J Clin Microbiol Infect Dis 2022; 41:37. doi:10.1007/s10096-021-04324-0
- ER Wald and GP DeMuri. Antibiotic recommendations for acute otitis media and acute bacterial sinusitis: conundrum no more. Pediatr Infect Dis J 2018; 37:1255. doi:10.1097/inf.0000000000002009
- AS Lieberthal et al. Clinical practice guideline: the diagnosis and management of acute otitis media. Pediatrics 2013; 131:e964. doi:10.1542/peds.2012-3488
- ME Pichichero. Considering an otitis media antibiotic change. J Pediatr 2020; 222:253. doi:10.1016/j.jpeds.2020.04.021
- Global Initiative for Chronic Obstructive Lung Disease. 2023 GOLD report. Global strategy for prevention, diagnosis and management of COPD: 2023 report. Available at: https://bit.ly/42KEJyV. Accessed March 30, 2023.
- Adult immunization. Med Lett Drugs Ther 2022; 64:161.
- JP Metlay et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019; 200:e45. doi:10.1164/rccm.201908-1581st
- RL Woosley et al. QT drugs list. Available at: www.crediblemeds.org. Accessed December 15, 2022.
- JS Bradley et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53:e25. doi:10.1093/cid/cir531
- GS Tansarli and E Mylonakis. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother 2018; 62:e00635-18. doi:10.1128/aac.00635-18
- Delafloxacin (Baxdela) – a new fluoroquinolone antibiotic. Med Lett Drugs Ther 2018; 60:49.
- Omadacycline (Nuzyra) – a new tetracycline antibiotic. Med Lett Drugs Ther 2019; 61:74.
- Lefamulin (Xenleta) for community-acquired bacterial pneumonia. Med Lett Drugs Ther 2019; 61:145.
- Corticosteroids in community-acquired pneumonia. Med Lett Drugs Ther 2020; 62:7.
- FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease. February 22, 2018. Available at: https://bit.ly/3omrXlH. Accessed March 30, 2023.
- In brief: More fluoroquinolone warnings. Med Lett Drugs Ther 2018; 60:136.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Treatment of Common Respiratory Tract Infections
Article code: 1674a
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
